title: Systematic review of the psychometric properties of the questionnaire to evaluate the adherence to HIV therapy (CEAT-VIH).
abstract: BACKGROUND
  Since the use of the questionnaire to evaluate adherence to HIV therapy (acronym CEAT-VIH) has increased in the last decade and translation into new language versions has been requested, summarizing information regarding the psychometric properties of the instrument may be useful for researchers and practitioners.
  
  
  OBJECTIVE
  The purpose of this work was to review the psychometric properties of the questionnaire CEAT-VIH, available from published studies and research reports.
  
  
  METHODS
  Medline, PsycINFO, Google Scholar and Google; the searched period was from 2001 to 2012.
  
  
  METHODS
  Forty-eight research materials referring to the questionnaire CEAT-VIH were initially gathered from academic databases and direct contact with researchers, before being analyzed. From the initial pool of material compiled (i.e., abstracts, technical reports or database files, dissertations or complete articles), only 20 comprised original data.
  
  
  METHODS
  The selected research material described a variety of information in terms of the psychometric properties of the questionnaire. The results from the primary studies were then summarized in tables for evaluation, description and comparison.
  
  
  RESULTS
  Thirteen out of 16 studies reported a Cronbach's alpha value of above 0.70, supporting the internal consistency reliability of the CEAT-VIH questionnaire. No floor or ceiling effects were observed. Hypothesized relationships between the CEAT-VIH score and adherence-related variables (e.g., viral load, CD4+, compliance evaluated by physician or pharmacist, complexity of treatment and pill numbers) were observed, indicating validity evidence. Thus, variables expected to act as psychological risk factors for low adherence (e.g., stress, depression and anxiety) or protector factor (e.g., social support) to good adherence were observed. The scores of the questionnaire were also related to quality of life outcomes. Moreover, patients that received adherence intervention showed increased CEAT-VIH adherence scores. Sensitivity and specificity to correctly identify adherent patients with undetectable viral load were also observed for three studies.
  
  
  CONCLUSIONS
  Although the data provided in the reports were heterogeneous, these were valuable and reported enough evidence of validity for the instrument. The selected studies represented 41.7 % of those initially identified, and only eight out of 20 documents were peer reviewed.
  
  
  CONCLUSIONS
  The CEAT-VIH has been used for a variety of individuals of different ages, sex, socioeconomic and educational backgrounds. It has been a reliable and valid tool in measuring adherence to HIV treatment among different samples, and has been used with a wide range of study populations and countries (i.e., Brazil, Chile, Colombia, Mexico, Panama, Peru, Portugal, Puerto Rico, Romania and Spain). Encouraging data reported here may allow the recommendation of the CEAT-VIH as a valuable measure to use in HIV adherence research, especially in countries where the questionnaire already has available psychometric evidence.
authors.affiliation: Campus de la Universidad Autónoma de Madrid, Madrid, Spain. eduardo.remor@uam.es
authors.forename: Eduardo
authors.initials: E
authors.lastname: Remor
mesh_terms: D015658:HIV Infections / Q000188:drug therapy*; D006801:Humans; D055118:Medication Adherence; D011594:Psychometrics; D015203:Reproducibility of Results; D011795:Surveys and Questionnaires
references.citation: AIDS Behav. 2013 Jan;17(1):41-60
references.pmid: 22411426
references.citation: Curr Infect Dis Rep. 2012 Apr;14(2):185-93
references.pmid: 22351302
references.citation: AIDS Patient Care STDS. 2004 Sep;18(9):527-38
references.pmid: 15630773
references.citation: Rev Saude Publica. 2007 Oct;41(5):685-94
references.pmid: 17713708
references.citation: AIDS Patient Care STDS. 2003 Jul;17(7):325-32
references.pmid: 12952734
references.citation: J Clin Epidemiol. 2011 Mar;64(3):250-4
references.pmid: 21194887
references.citation: AIDS Res Hum Retroviruses. 2007 Oct;23(10):1166-75
references.pmid: 17961100
references.citation: AIDS Res Treat. 2010;2010:142076
references.pmid: 21490902
references.citation: J Gen Intern Med. 2004 Nov;19(11):1104-10
references.pmid: 15566439
references.citation: Ann Pharmacother. 2001 Sep;35(9):1010-5
references.pmid: 11573846
references.citation: AIDS Care. 2007 Feb;19(2):215-9
references.pmid: 17364401
references.citation: JAMA. 2006 Aug 9;296(6):679-90
references.pmid: 16896111
references.citation: Haemophilia. 2011 Sep;17(5):e901-5
references.pmid: 21649798
references.citation: AIDS Care. 2000 Jun;12(3):255-66
references.pmid: 10928201
references.citation: AIDS Behav. 2012 Jul;16(5):1085-91
references.pmid: 22491813
references.citation: Psychol Health Med. 2013;18(3):343-54
references.pmid: 22985131
references.citation: Patient Prefer Adherence. 2012;6:11-8
references.pmid: 22272065
references.citation: N Engl J Med. 2011 Aug 11;365(6):493-505
references.pmid: 21767103
references.citation: AIDS Behav. 2006 May;10(3):227-45
references.pmid: 16783535
references.citation: AIDS. 1999 Jun 18;13(9):1099-107
references.pmid: 10397541
references.citation: AIDS. 2012 Nov 28;26(18):2399-403
references.pmid: 22948266